Title : Angiotensin-converting enzyme inhibitor prevents skeletal muscle fibrosis in diabetic mice.

Pub. Date : 2021 Aug

PMID : 33998079






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ACE inhibitor administration prevents the increase in skeletal muscle fibrosis during the early phase after diabetes by streptozotocin. Streptozocin angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 Mus musculus
2 In this study, we therefore analyzed whether 1) increased skeletal muscle fibrosis in streptozotocin (STZ)-induced diabetic mice, and 2) a preventive effect on skeletal muscle fibrosis by administration by an ACE inhibitor. Streptozocin angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 Mus musculus
3 ACE inhibitor prevented both skeletal muscle fibrosis and muscle function in STZ mice. Streptozocin angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 Mus musculus